Dermal filler agents: a practical review

被引:89
作者
Johl, Sukhjit S.
Burgett, Richard A.
机构
[1] Permanente Med Grp Inc, Dept Ophthalmol, Sacramento, CA 95815 USA
[2] Kaiser Permanente Cosmet Serv, Sacramento, CA USA
[3] Indiana Univ, Med Ctr, Dept Ophthalmol, Oculofacial Surg Div, Indianapolis, IN USA
[4] Midwest Eye Inst, Indianapolis, IN USA
关键词
aging face; collagen; dermal fillers; filler agents; hyaluronic acid; soft-tissue augmentation;
D O I
10.1097/01.icu.0000243021.20499.4b
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose of review Facial aging results from multiple microscopic (histopathologic) and macroscopic (anatomic) changes. Whereas skin care and traditional surgery have much to offer patients desiring cosmetic improvement, they can fail to adequately address certain signs of facial aging. Soft-tissue augmentation with dermal fillers can successfully address these signs of aging by filling soft-tissue defects caused by age, scar formation, or disease. All dermal fillers aim to achieve the same goal: long-lasting soft-tissue augmentation without side effects. Each dermal filler preparation available for patient use has unique compositions and characteristics that impact its proper handling, therapeutic results, potential complications, and, ultimately, its ideal use. This review surveys the currently available preparations for soft-tissue augmentation. Recent findings A review of the medical literature and manufacturers' information are included for dermal fillers currently approved for use by the US Food and Drug Administration. The composition, use, and potential limitation of each available preparation are reviewed. Summary Dermal filling agents offer an excellent option for management of certain facial cosmetic changes. Since a wide range of products with significantly different characteristics is available, the treating physician should have sound knowledge of them all.
引用
收藏
页码:471 / 479
页数:9
相关论文
共 28 条
[11]  
Flaharty Patrick, 2004, Facial Plast Surg, V20, P165
[12]   Lip augmentation with liquid silicone [J].
Fulton, JE ;
Porumb, S ;
Caruso, JC ;
Shitabata, PK .
DERMATOLOGIC SURGERY, 2005, 31 (11) :1577-1586
[13]  
Glavas Ioannis P, 2005, Ophthalmol Clin North Am, V18, P249, DOI 10.1016/j.ohc.2005.03.003
[14]  
Hönig JF, 2003, J CRANIOFAC SURG, V14, P197
[15]   Orofacial granulomas after injection of cosmetic fillers.: Histopathologic and clinical study of 11 cases [J].
Lombardi, T ;
Samson, J ;
Plantier, F ;
Husson, C ;
Küffer, R .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2004, 33 (02) :115-120
[16]  
Lowe NJ, 2005, DERMATOL SURG, V31, P1616
[17]   Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane) [J].
Matarasso, SL ;
Carruthers, JD ;
Jewell, ML .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (03) :3S-34S
[18]   The evolution of soft tissue fillers in clinical practice [J].
Murray, CA ;
Zloty, D ;
Warshawski, L .
DERMATOLOGIC CLINICS, 2005, 23 (02) :343-+
[19]   Injectable skin fillers [J].
Narins, RS ;
Bowman, PH .
CLINICS IN PLASTIC SURGERY, 2005, 32 (02) :151-+
[20]   Soft tissue implants and fillers [J].
Owens, JM .
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2005, 38 (02) :361-+